U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Clinical Evaluation of a Neuroprotective Drug in Patients with Cervical Spondylotic Myelopathy Undergoing Surgical Treatment: Design and Rationale for the CSM-Protect Trial



Details

  • Personal Author:
  • Description:
    Study Design. Descriptive article and narrative review. Objective. To explain the rationale and design of the cervical spondylotic myelopathy (CSM)-Protect clinical trial that aims to elucidate the efficacy and safety of riluzole in the context of CSM. Summary of Background Data. CSM is the most common cause of spinal cord-related dysfunction internationally. Although surgery is effective in preventing the progression of impairment, and in some cases improving functional outcomes, many patients continue to exhibit significant disability in the postoperative setting. Evidence from preclinical studies suggests that glutamate-related excitotoxicity may contribute to the pathology of CSM and that administration of the sodium and glutamate-blocking medication riluzole, when combined with spinal cord decompression, may mitigate this effect and improve neurobehavioral outcomes. Although riluzole is FDA approved and has been shown to be safe and effective in the context of amyotrophic lateral sclerosis, its efficacy and safety in the context of CSM remain unknown. Methods. Descriptive article with narrative review of the literature. Results. In addition to providing pertinent preclinical background on the topic, this descriptive article and narrative review discusses the design and current status of an ongoing phase III randomized controlled trial evaluating the efficacy and safety of riluzole, combined with surgical decompression, in the treatment of CSM. Conclusion. On the basis of current projections, we estimate that the interim analysis for this study will take place in the spring of 2014, at which time an adaptive sample size adjustment may take place. [Description provided by NIOSH]
  • Subjects:
  • Keywords:
  • ISSN:
    0362-2436
  • Document Type:
    Text
  • Funding:
    Grant
  • Genre:
    Journal Article
  • Place as Subject:
  • CIO:
    National Institute for Occupational Safety and Health (NIOSH)
  • Topic:
    Workplace Safety & Health
  • Location:
    North America
  • Volume:
    38
  • Issue:
    22
  • NIOSHTIC Number:
    nn:20056415
  • Citation:
    Spine 2013 Oct; 38(22) (Suppl 1):S68-S75
  • Contact Point Address:
    Michael G. Fehlings, MD, PhD, FRCSC, FACS, University of Toronto, 399 Bathurst St, Toronto Western Hospital, Toronto, Ontario Canada
  • Email:
    Michael.Fehlings@uhn.on.ca
  • Federal Fiscal Year:
    2014
  • Performing Organization:
    University of Washington
  • Peer Reviewed:
    False
  • Start Date:
    20050701
  • Source Full Name:
    Spine
  • Supplement:
    1
  • End Date:
    20250630
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:4f6cba827083ac82c2787e0704eed8fb2eb648f293ffd87f40c285a4a43da457dd8afba18095b938b9a84427dc95bdc836ca37dc0e8305abaeab9117eb024ca9
  • Download URL:
  • File Type:
    Filetype[PDF - 231.94 KB ]
PREVIOUS
ON THIS PAGE
Details
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
BACK TO TOP